Pilocytic astrocytomas as hamartomas: Implications for treatment

British Journal of Ophthalmology

Volumn 92, Issue 1, 2008, Pages 3-6

  Parsa, C F ^a   Givrad, S ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; ANTINEOPLASTIC AGENT;

ASTROCYTOMA; BLOOD VESSEL OCCLUSION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CEREBELLUM INJURY; CLINICAL EFFECTIVENESS; DEVELOPMENTAL DISORDER; DRUG EFFICACY; EDITORIAL; ENDOCRINE DISEASE; HAMARTOMA; HUMAN; HYDROCEPHALUS; INFECTION; IONIZING RADIATION; MALIGNANT TRANSFORMATION; MENTAL DEFICIENCY; NEUROIMAGING; PILOCYTIC ASTROCYTOMA; PRIORITY JOURNAL; TUMOR LOCALIZATION; UNSPECIFIED SIDE EFFECT; WORLD HEALTH ORGANIZATION; BRAIN DISEASE; BRAIN TUMOR; RADIATION INJURY; RADIOTHERAPY; SECOND CANCER; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; ASTROCYTOMA; BRAIN DISEASES; BRAIN NEOPLASMS; HAMARTOMA; HUMANS; NEOPLASMS, SECOND PRIMARY; RADIATION INJURIES; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 38349166946     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.124941     Document Type: Editorial

References (108)

1. Palma L, Guidetti B. Cystic pilocytic astrocytomas of the cerebral hemispheres. Surgical experiences with 51 cases and long-term results. J Neurosurg 1985;62:811-5.
2. Ilgren EB, Stiller CA. Cerebellar astrocytomas: therapeutic management. Acta Neurochir (Wien) 1986;81:11-26.
3. Kocks W, Kalff R, Reinhardt V, et al. Spinal metastasis of pilocytic astrocytoma of the chiasma opticum. Childs Nerv Syst 1989;5:118-20.
4. Pollack IF, Claassen D, Al-Shboul Q, et al. Low-grade gliomas of cerebral hemispheres in children: an analysis of 71 cases. J Neurosurg 1995;82:536-47.
5. Haapasalo H, Sallinen SL, Sallinen P, et al. Clinicopathologic correlation of cell proliferation, apoptosis and p53 in cerebelar pilocytic astrocytomas. Neuropathol Appl Neurobiol 1999;25:123-42.
6. Glaser JS, Hoyt WF, Corbett J. Visual morbidity with chiasmal glioma. Long-term studies of visual fields in untreated and irradiated cases. Arch Ophthalmol 1971;85:3-12.
7. Bernstein M, Hoffman HJ, Halliday WC. Thalamic tumors in children. Long-term follow-up and treatment guidelines. J Neurosurg 1984;61:649-56.
8. Afra D, Muller W, Slowik F, et al. Supratentorial lobar pilocytic astrocytomas: report of 45 operated cases, including 9 recurrences. Acta Neurochir (Wien) 1986;81:90-3.
9. Austin EJ, Alvord EC, Recurrences of cerebellar astrocytomas: a violation of Collin's Law. J Neurosurg 1988;68:41-7.
10. Sgouros S, Fineron PW, Hockley AD. Cerebellar astrocytoma of childhood: long-term follow-up. Childs Nerv Syst 1995;11:89-96.
11. Listernick R, Charrow J, Gutmann DH. Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet 1999;89:38-44.
12. Packer RJ, Savino PJ, Bilaniuk LT, et al. Chiasmatic gliomas of childhood. A reappraisal of natural history and effectiveness of cranial irradiation. Childs Brain 1983;10:393-403.
13. Rivera-Luna R, Zapata-Tarrés M, Medina-Sansón A, et al. Long-term survival in children under 3 years of age with low-grade astrocytoma. Childs Nerv Syst 2007;23:543-7.
14. Packer RJ, Lange B, Ater J, et al. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 1993;11:850-6.
15. Packer RJ, Sutton LN, Bilaniuk LT, et al. Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: an update. Ann Neurol 1988;23:79-85.
16. Garvey M, Packer RJ. An integrated approach to the treatment of chiasmatic-hypothalamic gliomas. J Neurooncol 1996;28:167-83.
17. Ringertz N, Nordenstam H. Cerebellar astrocytoma. J Neuropathol Exp Neurol 1951;10:343-67.
18. Bernell WR, Kepes JJ, Seitz EP. Late malignant recurrence of childhood cerebellar astrocytoma. J Neurosurg 1972;37:470-4.
19. Scott RM, Ballantine HT. Cerebellar astrocytoma: malignant recurrence after prolonged postoperative survival. J Neurosurg 1973;39:777-9.
20. Budka H. Partially resected and irradiated cerebellar astrocytoma of childhood: malignant evolution after 28 Years. Acta Neurochir (Wien) 1975;32:139-46.
21. Mullaney J, Walsh J, Lee WR, et al. Recurrence of astrocytoma of optic nerve after 48 years. Br J Ophthalmol 1976;60:539-43.
22. Wilson WB, Feinsod M, Hoyt WF, et al. Malignant evolution of childhood chiasmal pilocytic astrocytoma. Neurology 1976;26:322-5.
23. Kleinman GM, Schoene WC, Walshe TM 3rd, et al. Malignant transformation in benign cerebellar astrocytoma. J Neurosurg 1978;49:111-8.
24. Yanoff M, Davis RL, Zimmerman LE. Juvenile pilocytic astrocytoma ("glioma") of optic nerve: clinicopathologic study of sixty-three cases. In: Jakobiec FA, ed. Ocular and adnexal tumors. Birmingham: Aesculapius, 1978;685-707
25. Borit A, Richardson EP Jr. The biological and clinical behaviour of pilocytic astrocytomas of the optic pathways. Brain 1982;105:161-87.
26. Alpers CE, Davis RL, Wilson CB. Persistence and late malignant transformation of childhood cerebellar astrocytoma. J Neurosurg 1982;57:548-51.
27. Steinberg GK, Shuer LM, Conley FK, et al. Evolution and outcome in malignant astroglial neoplasms of the cerebellum. J Neurosurg 1985;62:9-17.
28. Zülch KJ. Brain tumors. Their biology and pathology. 3rd edn. Berlin: Springer, 1986:239-40.
29. Dropcho EJ, Wisoff JH, Walker RW, et al. Supratentorial malignant gliomas in childhood: a review of fifty cases. Ann Neurol 1987;22:355-64.
30. Ushio Y, Arita N, Yoshimine T, et al. Malignant recurrence of childhood cerebellar astrocytoma: case report. Neurosurgery 1987;21:251-5.
31. Wallner KE, Gonzales MF, Edwards MS, et al. Treatment results of juvenile pilocytic astrocytoma. J Neurosurg 1988;69:171-6.
32. Nishio S, Takeshita I, Fukui M, et al. Anaplastic evolution of childhood optico-hypothalamic pilocytic astrocytoma: report of an autopsy case. Clin Neuropathol 1988;7:254-8.
33. Wisoff HS, Llena JF. Glioblastoma multiforme of the cerebellum five decades after irradiation of a cerebellar tumor. J Neurooncol 1989;7:339-44.
34. Russell DS, Rubinstein LJ. Astrocytomas. In: Pathology of tumors of nervous system. 5th edn. London: Arnold, 1989:95-160, 370-6
35. Morota N, Sakamoto K, Kobayashi N, et al. Recurrent low-grade glioma in children with special reference to computed tomography findings and pathological changes. Childs Nerv Syst 1990;6:155-60.
36. Schwartz AM, Ghatak NR. Malignant transformation of benign cerebellar astrocytoma. Cancer 1990;65:333-6.
37. Casadei GP, Arrigoni GL, D'Angelo V, et al. Late malignant recurrence of childhood cerebellar astrocytoma. Clin Neuropathol 1990;9:295-8.
38. Tomlinson FH, Scheithauer BW, Hayostek CJ, et al. The significance of atypia and histologic malignancy in pilocytic astroytoma of the cerebellum: a clinicopathologic and flow cytometric study. J Child Neurol 1994;9:301-10.
39. Katsetos CD, Krishna L. Lobar pilocytic astrocytomas of the cerebral hemispheres: I. Diagnosis and nosology. Clin Neuropathol 1994;13:295-305.
40. Dirks PB, Jay V, Becker LE, et al. Development of anaplastic changes in low-grade astrocytomas of childhood. Neurosurgery 1994;34:68-78.
41. Jamjoom AB, Malabarey T, Jamjoom ZA. Cerebrovasculopathy and malignancy: catastrophic complications of radiotherapy for optic nerve glioma in a von Recklinghausen neurofoibromatosis patient. Neurosurg Rev 1996;19:47-51.
42. Claus D, Sieber E, Engelhardt A, et al. Ascending central nervous spreading of a spinal astrocytoma. J Neurooncol 1996;25:245-50.
43. Dirven CMF, Mooij JJA, Molenaar WM. Cerebellar pilocytic astrocytoma: a treatment protocol based upon analysis of 73 cases and a review of the literature. Childs Nerv Syst 1997;13:17-23.
44. Krieger MD, Gonzalez-Gomez I, Levy ML, et al. Recurrence patterns and anaplastic change in a long-term study of pilocytic astrocytomas. Pediatr Neurosurg 1997;27:1-11.
45. Kuroiwa T, Ohta T, Tsutsumi A. Malignant pilocytic astrocytoma in the medulla oblongata: case report. Brain Tumor Pathol 1999;16:81-5.
46. Lach B, Shail EAL, Patay Z. Spontaneous anaplasia in pilocytic astrocytoma of cerebellum. Br J Neurosurg 2003;17:250-2.
47. Van der Wal EPJ, Azzarelli B, Edwards-Brown M. Malignant transformation of a chiasmatic pilocytic astrocytoma in a patient with diencephalic syndrome. Pediatr Radiol 2003;33:207-10.
48. Canesso A, Gardiman M, Salmaso R, et al. An unusual case of malignant pilocytic astrocytoma occurring in the eye. Virchows Arch 2006;449:248-52.
49. Hudson AC. Primary tumours of optic nerve. Roy Lond Ophthalmol Hosp Rep 1912;18:317-439.
50. Hoyt WF, Baghdassarian SA. Optic glioma of childhood. Br J Ophthalmol 1969;53:793-8.
51. Parsa CF, Givrad S. Juvenile pilocytic astrocytomas do not undergo spontaneous malignant transformation. Grounds for designation as hamartomas. Br J Ophthalmol 2008;92:40-6.
52. Brzowski AE, Bazan C III, Mumma JV, et al. Spontaneous regression of optic glioma in a patient with neurofibromatosis. Neurology 1992;42:679-81.
53. Parazzini C, Triulzi F, Bianchini E, et al. Spontaneous involution of optic pathway lesions in neurofibromatosis type 1: serial contrast MR evaluation. AJNR Am J Neuroradiol 1995;16:1711-8.
54. Gottschalk S, Tavakolian R, Buske A, et al. Spontaneous remission of chiasmatic/hypothalamic masses in neurofibromatosis type 1: report of two cases. Neuroradiology 1999;41:199-201.
55. Perilongo G, Moras P, Carollo C, et al. Spontaneous partial regression of low grade glioma in children with neurofibromatosis-1: a real possibility. J Child Neurol 1999;14:352-6.
56. Schmandt SM, Packer RJ, Vezina LG, et al. Spontaneous regression of low grade astrocytomas in childhood. Pediatr Neurosurg 2000;32:132-6.
57. Colosimo C, Cerase A, Maira G. Regression after biopsy of a pilocytic opticochiasmatic astrocytoma in a young adult without neurofibromatosis. Neuroradiology 2000;42:352-6.
58. Zuccoli G, Ferrozzi F, Sigorini M, et al. Early spontaneous regression of a hypothalamic/chiasmatic mass in neurofibromatosis type 1: MR findings. Eur Radiol 2000;10:1076-8.
59. Parsa CF, Hoyt CS, Lesser RL, et al. Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging. Arch Ophthalmol 2001;119:516-29.
60. Astrup J. Natural history and clinical management of optic pathway glioma. Br J Neurosurg 2003;17:327-35.
61. Piccirilli M, Lenzi J, Delfinis C, et al. Spontaneous regression of optic pathways gliomas in three patients with neurofibromatosis type I and critical review of literature. Childs Nerv Syst 2006;22:1332-7.
62. Anderson DR, Spencer WH. Ultrastructural and histochemical observations of optic nerve gliomas. Arch Ophthalmol 1970;83:324- 35.
63. Ito S, Hoshino T, Shibuya M, et al. Proliferative characteristics of juvenile pilocytic astrocytomas determined by bromodeoxyuridine labeling. Neurosurgery 1992;31:413-8.
64. Li J, Perry A, James CD, Gutmann DH. Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas. Neurology 2001;56:885-90.
65. Burger PC, Scheithauer BW, Paulus W, et al. Pilocytic astrocytoma. In: Kleihues P, Cavenee WK, eds. World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. Lyon: IARC Press, 2000:45-51.
66. Singhal S, Birch JM, Kerr B, et al. Neurofibromatosis type I and sporadic optic gliomas. Arch Dis Child 2002;87:65-70.
67. Sharif S, Ferner R, Birch J, et al. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol 2006;24:2570-5.
68. Parsa CF. Optic Gliomas. In: Roy FH, Fraunfelder FW, Fraunfelder FT, eds. Roy and Fraunfelder's current ocular therapy. 6th edn. Philadelphia: Saunders. 2008:262-4.
69. Duffner PK, Cohen ME, Thomas PRM, et al. The long-term effects of cranial irradiation on central nervous system. Cancer 1985;56:1841-6.
70. Pierce SM, Barnes PD, Loefler JS, et al. Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long-term effects. Cancer 1990;65:45-52.
71. Livesey EA, Hindmarsh PC, Brook CGD, et al. Endocrine disorders following treatment of childhood brain tumours. Br J Cancer 1990;61:622-5.
72. Donahue B. Short- and long-term complications of radiation therapy for pediatric brain tumors. Pediatr Neurosurg 1992;18:207-17.
73. Epstein MA, Packer RJ, Rorke LB, et al. Vascular malformation with radiation vasculopathy after treatment of chiasmatic/ hypothalamic glioma. Cancer 1992;70:887-93.
74. Knudson AG. Hereditary predisposition to cancer. Ann NY Acad Sci 1997;29:833-67.
75. Eyre HJ, Crowley JJ, Townsend JJ, et al. A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. J Neurosurg 1993;78:909-14.
76. Massimino M, Spreafico F, Cefalo G, et al. High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 2002;20:4209-16.
77. Friedman HS, Krischer JP, Burger P, et al. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: A pediatric oncology group randomized phase II study. J Clin Oncol 1992;10:249-56.
78. Perry A. Pathology of low-grade gliomas: An update of emerging concepts. Neuro-oncol 2003;5:168-78.
79. Evans DGR, Birch JM, Ramsden RT, et al. Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes. J Med Genet 2006;43:289-94.
80. Kortmann RD, Timmermann B, Taylor RE, et al. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment related late toxicities. Strahlenther Onkol 2003;179:585-97.
81. Buyukpamukcu M, Varan A, Yazici N, et al. Second malignant neoplasms following the treatment of brain tumors in children. J Child Neurol 2006;21:433-6.
82. Rafiei N, Parsa CF. Neurofibromatosis type 1. In: Roy FH, Fraunfelder FW, Fraunfelder FT, eds. Roy and Fraunfelder's current ocular therapy. 6th edn. Philadelphia: Saunders, 2008:193-5.
83. Rheingold SR, Neugut AI, Meadows AT. Secondary cancers: Incidence, risk factors and management. In: Bast RC, Kufe DW, Pollock RE, et al Cancer medicine. 5th edn. Hamilton: Decker, 2000:2399-405.
84. Chao RC, Pyzel U, Fridlyand J, et al. Therapy-induced malignant neoplasms in NF1 mutant mice. Cancer Cell 2005;8:337-48.
85. Sherr CJ. Principles of tumor suppression. Cell 2004;116:235-46.
86. Vogelstein B, Kinzler KW. Cancer genes and pathways they control. Nat Med 2004;10:789-99.
87. Knudson AG. Cancer genetics. Am J Med Gen 2002;111:96-102.
88. Burger PC, Scheithauer BW. Tumors of the central nervous system. AFIP atlas of tumor pathology. Fourth series. Fascicle 7. Washington, DC: American Registry of Pathology, 2007:89-102.
89. Zimmer-Galler IE, Robertson ADM. Long-term observation of retinal lesions in tuberous sclerosis. Am J Ophthalmol 1995;119:318-24.
90. Nakamizo A, Inamura T, Ikezaki K, et al. Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors. J Neurooncol 2002;57:105-14.
91. van der Hoeve J. Augengeschwülste bei der tuberösen hirnsklerose (Bourneville). Albrecht von Graefes Arch Ophthalmol 1921;105:880-98.
92. Gündüz K, Eagle RC Jr, Shields CL, et al. Invasive giant cell astrocytoma of the retina in a patient with tuberous sclerosis. Ophthalmology 1999;106:639-42.
93. Shields CL, Shields JA, Eagle RC Jr, et al. Progressive enlargement of acquired retinal astrocytoma in 2 cases. Ophthalmology 2004;111:363-8.
94. Song S, Seo MS. Spontaneous regression of a solitary astrocytoma of the optic disk. Retina 2002;22:502-3.
95. Kiratli H, Bilgic S. Spontaneous regression of retinal astrocytic hamartoma in a patient with tuberous sclerosis. Am J Ophthalmol 2002;133:715-6.
96. De Juan E Jr, Green WR, Gupta PK, et al. Vitreous seeding by retinal astrocytic hamartoma in a patient with tuberous sclerosis. Retina 1984;4:100-2.
97. van der Hoeve J. Eye symptoms in tuberose sclerosis of the brain. Trans Ophthal Soc UK 1920;40:329-34.
98. van der Hoeve J. Eye diseases in tuberous sclerosis of the brain and in Recklinghausen's disease. Trans Ophthal Soc UK 1923;43:534-41.
99. Van der Hoeve J. The Doyne Memorial Lecture: Eye symptoms in phakomatoses. Trans Ophthalmol Soc UK 1932;52:380-401.
100. Albrecht E. Ueber Hamartome. Verh Dtsch Ges Pathol 1904;7:153-7.
101. Albrecht E. Die Grundprobleme der Geschwulstlehre. I. Teil. Frankf Z Pathol 1907;1:221-47.
102. Glass J, Silverman CL, Corn B, et al. Possible early emergence of in-field second neoplasms following cranial irradiation, chemotherapy, and stereotactic irradiation: report of two cases. J Radiosurg 1998;1:59-62.
103. Bhatia S, Sklar C. Second cancers in survivors of childhood cancer. Nat Rev Cancer 2002;2:124-32.
104. Fontana M, Stanton C, Pompili A, et al. Late multifocal gliomas in adolescents previously treated for acute lymphoblastic leukemia. Cancer 1987;60:1510-8.
105. Maris JM, Wiersma SR, Mahgoub N, et al. Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1. Cancer 1997;79:1438-46.
106. Papageorgio C, Seiter K, Feldman EJ. Therapy-related myelodysplastic syndrome in adults with neurofibromatosis. Leuk Lymphoma 1999;32:605-8.
107. Wesseling P, Ruiter DJ, Burger PC. Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neurooncol 1997;32:253-65.
108. Franz DN, Leonard J, Tudor C, et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 2006;59:490-8.